pSC-humanADAR1
(Plasmid
#198235)
-
PurposeExpresses human ADAR1 in yeast
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 198235 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBR322
-
Backbone manufacturerHerbert Boyer at the University of California, San Francisco
- Backbone size w/o insert (bp) 4361
-
Modifications to backboneplasmid is based on the YEpTOP2PGAL1 vector used to express DNA topoisomerase (Giaever GN, Snyder L, Wang JC. DNA supercoiling in vivo. Biophys Chem. 1988;29:7–15.)
-
Vector typeYeast Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namehuman ADAR1
-
Alt nameADAR
-
SpeciesH. sapiens (human)
-
Entrez GeneADAR (a.k.a. ADAR1, AGS6, DRADA, DSH, DSRAD, G1P1, IFI-4, IFI4, K88DSRBP, P136)
- Promoter GAL1
-
Tag
/ Fusion Protein
- His10_TEV (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (unknown if destroyed)
- 3′ cloning site XhoI (unknown if destroyed)
- 5′ sequencing primer TGGAAATGTAAAGAGCCCC
- 3′ sequencing primer GAAGTGATCACCAAAGGC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSC-humanADAR1 was a gift from Brenda Bass (Addgene plasmid # 198235 ; http://n2t.net/addgene:198235 ; RRID:Addgene_198235) -
For your References section:
Predicting sites of ADAR editing in double-stranded RNA. Eggington JM, Greene T, Bass BL. Nat Commun. 2011;2:319. doi: 10.1038/ncomms1324. 10.1038/ncomms1324 PubMed 21587236